View profile on ResearchGate

Positions

  • Professor of Medicine; The University of Queensland
  • Director, Centre for Chronic Disease, Centre for Clinical Research, Faculty of Medicine, The University of Queensland
  • Director; Kidney Disease Research and Prevention
  • Honorary Professorial Fellow, Baker IDI and Diabetes Institute

Qualifications

  • BScMed (Hons 1) (The University of Sydney)
  • MBBS (Hons 1) (The University of Sydney)
  • Americal Board of Internal Medicine (Medicine)
  • American Board of Internal Medicine (Nephrology)
  • Fellow, Royal Australian College of Physicians

Professional memberships and associations

  • American Society of Nephrology
  • Australian and New Zealand Society of Nephrology
  • Royal Australian College of Physicians
  • International Society of Nephrology

Current projects/grants

  • Birth weight, adult weight and podocyte depletion. NHMRC APP1065902
  • Centre of Research Excellence in Chronic Kidney Disease in Australia. NHMRC CRE APP1079502
  • Periodontal disease and chronic kidney disease among Aboriginal adults; an RCT. NHMRC APP1078077
  • CKD.QLD Registry and Database 
  • Building a simulation model to improve cardiovascular disease risk prediction and treatment for indigenous Australians. Research Support. NHMRC APP1107140
  • aCQuiRE Study. Sanofi-Genzyme GZ-2015-11442

 

 

 

Researcher biography

Professor Wendy Hoy is Director of the Centre for Chronic Disease at the University of Queensland. She completed secondary education at Telopea Park High School in Canberra, with the top score in the leaving certificate of all students in NSW and the ACT. She is a graduate of Sydney University, with first class honours in Immunology (BScMed) and in Medicine and Surgery (MB BS), and is board certified in Medicine and Nephrology in the USA and Australia.

She is recognised internationally for her multidisciplinary research into kidney and related chronic disease, particularly in high-risk populations, for which she received the Australia Research Fellowship in 2009, and was appointed an Officer of the Order of Australia (AO) in 2010.  She is a Fellow of the Australian Academy of Science (FAA), an incoming member (May 2018) of the Academy’s Council (biomedical stream), and represents the Academy on the Health in All Policies, International Program.

She was among the first to describe kidney disease, independent of diabetes in Native Americans, in studies of Zuni and Rio Grande Pueblo Indians as well as Navaho and Apache Indians in the Southwest of the USA. She promotes an integrated view of non-communicable chronic diseases, and interpretation of health profiles in multi-determinant disease models. She was the first to demonstrate the contribution of low birthweight to kidney disease in Australia. She showed that screening and treatment of early kidney disease in remote-living Australian Aboriginal reduces dialysis needs, deaths and costs. That work has helped transform Australian Aboriginal health services, and underpins many screening and treatment programs globally.  She has described the transformation of mortality in remote-living Aborigines over the last 50 years, and the links of that epidemiologic transition to current health profiles and population size and structure.  She and her colleagues have conducted the only nationwide study of kidney biopsies in Australia, defining the high rates of enlargement and scarring of kidney filters. They have also defined, in a 20-year study of the largest series of kidney autopsies in the world, which encompasses five ethnic groups in three continents, the range of nephron numbers and glomerular volume in normal kidneys, and the structural features that mark heightened susceptibility to kidney disease and high blood pressure.

Current work includes investigations of low birthweight and prematurity as determinants of adult health, genetic determinants of kidney disease in Aborigines, APOL1-risk allele-associated disease in African-Americans, and links of chronic diseases to fetal alcohol exposure. She continues to lead the longitudinal Tiwi Islands kidney project, now in its 26th year.  She consults with Central American agencies and with Sri Lanka in chronic disease (CKD) of unknown etiology. She also leads the CKD.QLD Collaborative and the NHMRC CKD Centre for Research Excellence. CKD.QLD is a core member of the iNET-CKD, an international research collaborative of CKD cohorts.

Find out more information on how to apply for a Research Higher Degree (MPhil or PhD). For all enquiries regarding research supervision, please contact us.